Declines seen regardless of service type, setting, or specialty, and state or region
MONDAY, April 5, 2021 (HealthDay News) — Medicare spending on physician services declined an estimated $9.4 billion between January and June 2020, according to a report from the American Medical Association (AMA).
Kurt Gillis, Ph.D., on behalf of the AMA, used claims data to assess Medicare fee-for-service spending for the first six months of 2020, with a focus exclusively on Medicare physician fee schedule (MPFS) services.
The AMA reports that MPFS spending for the first six months of 2020 totaled $39 billion, down 19 percent from the expected spending for this period of $48.4 billion. Evaluation and management (E/M) spending fell nearly 50 percent by late March before leveling off, while spending for imaging, procedures, and tests continued to drop until mid-April (65 to 70 percent below expected 2020 spending). For all major settings, spending lows were reached in April (range: −25 percent for skilled nursing facilities to −90 percent for ambulatory surgical centers). By the end of June, spending recovered for all settings, but remained 9 to 19 percent below expected. Spending declines varied among specialties (range: −6 percent for nephrology to −34 percent for physical therapists). Regional patterns of impact showed the biggest reductions concentrated in the Northeast and Upper Midwest, which were hit hardest early in the pandemic. Telehealth was concentrated in a few service categories, but increased from less than 0.1 percent of total Medicare spending on physician services prior to the pandemic to more than 16 percent in April 2020.
“The economic impact of the COVID-19 pandemic has placed significant financial stress on medical practices as expenses have spiked and revenues have dropped,” Susan R. Bailey, M.D., president of the AMA, said in a statement.
More Than 1 in 4 Americans Misrepresent Symptoms to Get Antibiotics
Hospital Outcomes Better When Patients Treated by Female Physicians
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Maternal Night-Shift Work Tied to Later Neurodevelopmental Issues in Offspring
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel